The weak nature of this correlation could be due to the fact that response to CTX in HPV‐negative HNSCC is not entirely assessable by the level of EGFR activation, but needs a multiparametric assessment, as recently demonstrated (Huang et al,2021). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.